These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37680235)

  • 1. Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.
    Coll-Martinez C; Salavedra-Pont J; Buxó M; Quintana E; Quiroga-Varela A; Robles-Cedeño R; Puig M; Álvarez-Bravo G; Ramió-Torrentà L; Gich J
    Front Psychol; 2023; 14():1163112. PubMed ID: 37680235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
    Jackson DA; Nicholson R; Bergmann C; Wilken J; Kaczmarek O; Bumstead B; Buhse M; Zarif M; Penner IK; Hancock LM; Golan D; Doniger GM; Bogaardt H; Barrera M; Covey TJ; Gudesblatt M
    Mult Scler Relat Disord; 2023 Jan; 69():104410. PubMed ID: 36399966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pupil response speed as a marker of cognitive fatigue in early Multiple Sclerosis
    Guillemin C; Hammad G; Read J; Requier F; Charonitis M; Delrue G; Vandeleene N; Lommers E; Maquet P; Collette F
    Mult Scler Relat Disord; 2022 Sep; 65():104001. PubMed ID: 35803086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis.
    Covey TJ; Golan D; Doniger GM; Sergott R; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Mebrahtu S; Bergmann C; Wilken J; Gudesblatt M
    Mult Scler Relat Disord; 2022 Jan; 57():103349. PubMed ID: 35158458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive fatigue-related sensory gating deficits in people with multiple sclerosis.
    Linnhoff S; Haghikia A; Zaehle T
    Neurobiol Dis; 2023 Jan; 176():105950. PubMed ID: 36493977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls.
    Postigo-Alonso B; Galvao-Carmona A; Conde-Gavilán C; Jover A; Molina S; Peña-Toledo MA; Valverde-Moyano R; Agüera E
    PLoS One; 2019; 14(12):e0226775. PubMed ID: 31869375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between subjective and objective cognitive performance in multiple sclerosis.
    Rosti-Otajärvi E; Ruutiainen J; Huhtala H; Hämäläinen P
    Acta Neurol Scand; 2014 Nov; 130(5):319-27. PubMed ID: 24571681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis.
    Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L
    Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cognitive fatigue and fatigability in multiple sclerosis.
    Mackay L; Johnson AM; Moodie ST; Rosehart H; Morrow SA
    Mult Scler Relat Disord; 2021 Nov; 56():103316. PubMed ID: 34638096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Word finding, prosody and social cognition in multiple sclerosis.
    Yap SM; Davenport L; Cogley C; Craddock F; Kennedy A; Gaughan M; Kearney H; Tubridy N; De Looze C; O'Keeffe F; Reilly RB; McGuigan C
    J Neuropsychol; 2023 Mar; 17(1):32-62. PubMed ID: 35822290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the mechanisms of fatigue in multiple sclerosis: linking interoception, metacognition and white matter dysconnectivity.
    Danciut I; Rae CL; Rashid W; Scott J; Bozzali M; Iancu M; Garfinkel SN; Bouyagoub S; Dowell NG; Langdon D; Cercignani M
    Brain Commun; 2024; 6(5):fcae292. PubMed ID: 39291169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and patterns of subclinical motor and cognitive impairments in non-disabled individuals with early multiple sclerosis: A multicenter cross-sectional study.
    Cattaneo D; Gervasoni E; Anastasi D; Di Giovanni R; Brichetto G; Carpinella I; Cavalla P; Confalonieri P; Groppo E; Prosperini L; Tacchino A; Rovaris M; Solaro C
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101491. PubMed ID: 33454397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotional Recognition and Its Relation to Cognition, Mood and Fatigue in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
    Argento O; Piacentini C; Bossa M; Nocentini U
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory-Motor and Affective-Fatigue Factors are Associated with Symbol Digit Performance in Multiple Sclerosis.
    Arnett PA; Cadden M; Roman CAF; Guty E; Riegler K; Thomas G
    J Int Neuropsychol Soc; 2022 Apr; 28(4):362-370. PubMed ID: 34294175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective Report, Objective Neurocognitive Performance, and "Invisible Symptoms" in Multiple Sclerosis.
    Thomas GA; Riegler KE; Bradson ML; O'Shea DU; Arnett PA
    Arch Clin Neuropsychol; 2023 Feb; 38(2):169-181. PubMed ID: 36321349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.